Skip to main content

Soleno Therapeutics Inc

SLNODelisted May 18, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001484565

Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Soleno Therapeutics Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of SLNO: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders6347−16
Shares32.7M29.6M−3.10M (−9.5%)
Value$41.2M$33.6M−$7.56M (−18.4%)

New holders (10)

Institutions that held Soleno Therapeutics Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to SLNO in Q2 2021
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC374,185$427.0K0.00%
SG Americas Securities, LLC299,074$341.0K0.00%
Tibra Equities Europe Ltd298,700$341.0K0.11%
Ergoteles LLC270,700$309.0K0.01%
Millennium Management LLC194,965$222.0K0.00%
Bollard Group LLC34,322$39.0K0.00%
Two Sigma Securities, LLC19,219$22.0K0.01%
LMR Partners LLP19,500$22.0K0.00%
Y-Intercept (Hong Kong) Ltd13,574$15.0K0.00%
Advisor Group Holdings, Inc.3,040$3.00K0.00%

Sold out (26)

Institutions that held Soleno Therapeutics Inc at the end of Q1 2021 and filed for Q2 2021 without it.